Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. The dynamics we have seen over the last eighteen months, including U.S. prices for injectable ...

Hims & Hers Health (NYSE:HIMS) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize ...

The company forecast full-year 2026 revenue of $2.7 billion to $2.9 billion and Q1 revenue of $600 million to $625 million, ...

Hims & Hers Health, Inc. ( HIMS) Q4 2025 Earnings Call February 23, 2026 5:00 PM EST ...

Q4 2025 earnings call recap: revenue, EBITDA, subscriber growth, new specialties, and international expansion outlook.

In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on the ...

The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.

Hims & Hers is one of the leading telehealth firms in the US. Since its 2017 launch, the platform has connected patients with healthcare providers across specialties including erectile dysfunction, ...

Marking one year in office, Delhi Chief Minister Rekha Gupta on Friday presented an overview of the state government’s ...

By Sneha S K and Amina Niasse Feb 23 (Reuters) - Online telehealth company Hims & Hers Health, which sells weight-loss drugs, ...

Workers at an Australian start-up have become overnight millionaires as more than after a US telehealth giant swooped in with ...

The telehealth platform said it expects growth to continue this year, though its first quarter guidance [came in short]( ...